Abstract
Prion diseases such as bovine spongiform encephalopathy and Creutzfeldt-Jakob disease are fatal neurodegenerative diseases. These diseases are characterized by the conversion of a normal cellular protein, the prion protein, to an abnormal isoform that is thought to be responsible for both pathogenesis in the disease and the infectious nature of the disease agent. Understanding the biology and metabolism of the normal prion protein is therefore important for understanding the nature of these diseases. This review presents evidence for the normal function of the cellular prion protein, which appears to depend on its ability to bind copper (Cu). There is now considerable evidence that the prion protein is an antioxidant. Once the prion protein binds Cu, it may have an activity like that of a superoxide dismutase. Conversion of the prion protein to an abnormal isoform might lead to a loss of antioxidant protection that could be responsible for neurodegeneration in the disease.
Similar content being viewed by others
References
Horwich, A. L. and Weissman, J. S. (1997) Deadly conformations—protein misfolding in prion disease. Cell 89, 499–510.
Liemann, S. and Glockshuber, R. (1998) Transmissible spongiform encephalopathies. Biochem. Biophys. Res. Commun. 250, 187–193.
Prusiner, S. B. (1997) Prion diseases and the BSE crisis. Science 278, 245–251.
Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144.
Basler, K., Oesch, B., Scott, M., et al. (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417–428.
Sparkes, R. S., Simon, M., Cohn, V. H., et al. (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc. Natl. Acad. Sci. USA 83, 7358–7362.
Locht, C., Chesebro, B., Race, R., and Keith, J. M. (1986) Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc. Natl. Acad. Sci. USA 83, 6372–6376.
Sendo, F., Suzuki, K., Watanabe, T., Takeda, Y., and Araki, Y. (1998) Modulation of leukocyte transendothelial migration by integrin-associated glycosyl phosphatidyl inositol (GPI)-anchored proteins. Inflamm. Res. 47 (Suppl. 3), S133-S136.
Gabriel, J. M., Oesch, B., Kretzschmar, H., Scott, M., and Prusiner, S. B. (1992) Molecular cloning of a candidate chicken prion protein. Proc. Natl. Acad. Sci. USA 89, 9097–9101.
Simonic, T., Duga, S., Strumbo, B., Asselta, R., Ceciliani, F., and Ronchi, S. (2000) cDNA cloning of turtle prion protein [In Process Citation]. FEBS Lett. 469, 33–38.
Booth, D. R., Sunde, M., Bellotti, V., et al. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [see comments]. Nature 385, 787–793.
Moore, R. C., Lee, I. Y., Silverman, G. L., et al. (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292, 797–817.
Sakaguchi, S., Katamine, S., Nishida, N., et al. (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380, 528–531.
Matthews, S., Barlow, P., Boyd, J., et al. (1994) Structural similarity between the p17 matrix protein of HIV-1 and interferon gamma. Nature 370, 666–668.
James, T. L., Liu, H., Ulyanov, N. B., et al. (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94, 10,086–10,091.
Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., and Wuthrich, K. (1996) NMR structure of the mouse prion protein domain PrP(121–321). Nature 382, 180–182.
Wildegger, G., Liemann, S., and Glockshuber, R. (1999) Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat. Struct. Biol. 6, 550–553.
Hornshaw, M. P., McDermott, J. R., and Candy, J. M. (1995) Cu-binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207, 621–629.
Brown, D. R., Qin, K., Herms, J. W., et al. (1997) The cellular prion protein binds Cu in vivo. Nature 390, 684–687.
Brown, D. R., Wong, B. S., Hafiz, F., Clive, C., Haswell, S., and Jones, I. M. (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344, 1–5.
Stöckel, J., Safar, J., Wallace, A. C., Cohen, F. E., and Prusiner, S. B. (1998) Prion protein selectively binds Cu(II) ions. Biochemistry 37, 7185–7193.
Viles, J. H., Cohen, F. E., Prusiner, S. B., Goodin, D. B., Wright, P. E., and Dyson, H. J. (1999) Cu-binding to the prion protein: Structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. USA 96, 2042–2047.
Miura, T., Hori-i, A., and Takeuchi, H. (1996) Metal-dependent alpha-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett. 396, 248–252.
Ruiz, F. H., Silva, E., and Inestrosa, N. C. (2000) The N-Terminal Tandem Repeat Region of Human Prion Protein Reduces Cu: Role of Tryptophan Residues. Biochem. Biophys. Res. Commun. 269, 491–495.
Shiraishi, N., Ohta, Y., and Nishikimi, M. (2000) The Octapeptide Repeat Region of Prion Protein Binds Cu(II) in the Redox-Inactive State. Biochem. Biophys. Res. Commun. 267, 398–402.
Wong, B. S., Wang, H., Brown, D. R., and Jones, I. M. (1999) Selective oxidation of methionine residues in prion proteins. Biochem. Biophys. Res. Commun. 259, 352–355.
Zhou, B. and Gitschier, J. (1997) hCTR1: a human gene for Cu uptake identified by complementation in yeast. Proc. Natl. Acad. Sci. USA 94, 7481–7486.
Hornshaw, M. P., McDermott, J. R., Candy, J. M., and Lakey, J. H. (1995) Cu-binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem. Biophys. Res. Commun. 214, 993–999.
Brown, D. R. (1999) Prion protein expression aids cellular uptake and veratridine-induced release of Cu. J. Neurosci. Res. 58, 717–725.
Jackson G. S., Murray I., Hosszu, L. L., et al. (2001) Location and properties of metal-binding sites on the human prion protein. Proc. Natl. Acad. Sci. USA 98, 8531–8535.
Brown, D. R., Herms, J., and Kretzschmar, H. A. (1994) Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 5, 2057–2060.
Giese, A., Brown, D. R., Groschup, M. H., Feldmann, C., Haist, I., and Kretzschmar, H. A. (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8, 449–457.
Brandner, S., Isenmann, S., Raeber, A., et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339–343.
Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1996) Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380, 345–347.
Brown, D. R., Schulz-Schaeffer, W. J., Schmidt, B., and Kretzschmar, H. A. (1997) Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146, 104–112.
Büeler, H., Aguzzi, A., Sailer, A., et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–1347.
Kuwahara, C., Takeuchi, A. M., Nishimura, T., et al. (1999) Prions prevent neuronal cell line death. Nature 400, 225–226.
Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1997) Expression of prion protein in PC12 is enhanced by exposure to oxidative stress. Int. J. Dev. Neurosci. 15, 961–972.
Brown, D. R. and Besinger, A. (1998) Prion protein expression and superoxide dismutase activity. Biochem. J. 334, 423–429.
White, A. R., Collins, S. J., Maher, F., et al. (1999) Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am. J. Pathol. 155, 1723–1730.
Perovic, S., Schroder, H. C., Pergande, G., Ushijima, H., and Muller, W. E. (1997) Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106–126) Exp. Neurol. 147, 518–524.
Brown, D. R., Nicholas, R. St. J., and Canevari, L. (2002) Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J. Neurosci. Res. 67, 211–224.
Huber, R., Deboer. T., and Tobler I. (2002) Sleep deprivation in prion protein deficient mice sleep deprivation in prion protein deficient mice and control mice: genotype dependent regional rebound. Neuroreport 13, 1–4.
Collinge, J., Whittington, M. A., Sidle, K. C., et al. (1994) Prion protein is necessary for normal synaptic function. Nature 370, 295–297
Guentchev, M., Voigtländer, T., Haberler, C., Groschup, M. H., and Budka, H. (2000) Evidence for oxidative stress in experimental prion disease. Neurobiol. Dis. 7, 270–273.
Wong, B.-S., Brown, D. R., Pan, T., et al. (2001a) Oxidative impairment in scrapie-infected mice is associated with brain metal perturbations and altered antioxidation activities. J. Neurochem. 79, 689–698.
Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1998b) Effects of Cu on survival of prion protein knockout neurons and glia. J. Neurochem. 70, 1686–1693.
Steinebach, O. M. and Wolterbeek, H. T. (1994) Role of cytosolic Cu, metallothionein and glutathione in Cu toxicity in rat hepatoma tissue culture cells. Toxicology 92, 75–90.
Brown, D. R., Clive, C., and Haswell, S. J. (2001) Antioxidant activity related to Cu-binding of native prion protein. J. Neurochem. 76, 69–76.
Stahl, N., Borchelt, D. R., and Prusiner, S. B. (1990) Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 29, 5405–5412.
Salès, N., Rodolfo, K., Hassig, R., Faucheux, B., Di Giamberardino, L., and Moya, K. L. (1998) Cellular prion protein localization in rodent and primate brain. Eur. J. Neurosci. 10, 2464–2471.
DiDonato, M. and Sarkar, B. (1997) Cu transport and its alterations in Menkes and Wilson diseases. Biochim. Biophys. Acta 1360, 3–16.
Vulpe, C. D. and Packman, S. (1995) Cellular Cu transport. Annu. Rev. Nutr. 15, 293–322.
Horn, N., Tonnesen, T., and Tümer, Z. (1992) Menkes disease: an x-linked neurological disorder of the Cu metabolism. Brain Pathol. 2, 351–362.
Hartmann, H. A. and Evenson, M. A. (1992) Deficiency of Cu can cause neuronal degeneration. Med. Hypotheses 38, 75–85.
Tanzi, R. E., Petrukhin, K., Chernov, I., et al. (1993) The Wilson disease gene is a Cu transporting ATPase with homology to the Menkes disease gene. Nat. Genet. 5, 344–350.
Cuthbert, J. A. (1995) Wilson’s disease: a new gene and an animal model for an old disease. J. Investig. Med. 43, 323–336.
Dijkstra, M., Vonk, R. J., and Kuipers, F. (1996) How does Cu get into bile? New insights into the mechanism(s) of hepatobiliary Cu transport. J. Hepatol. 24, 109–120.
Colburn, R. W. and Maas, J. W. (1965) Adenosine triphosphate-metal-norepinephrine ternary complexes and catecholamine binding. Nature 208, 37–41.
Rajan, K. S., Colburn, R. W., and Davis, J. M. (1976) Distribution of metal ions in the subcellular fractions of several rat brain areas. Life Sci. 18, 423–431.
Kardos, J., Kovacs, I., Hajos, F., Kalman, M., and Simonyi, M. (1989) Nerve endings from rat brain tissue release Cu upon depolarization. A possible role in regulating neuronal excitability. Neurosci. Lett. 103, 139–144.
Barnea, A. and Hartter, D. E., and Cho, G. (1989) High-affinity uptake of 67Cu into a veratridine-releasable pool in brain tissue. Am. J. Physiol. 257, C315–322.
Gabrielsson, B., Robson, T., Norris, D., and Chung, S. H. (1986) Effects of divalent metal ions on the uptake of glutamate and GABA from synaptosomal fractions. Brain Res. 384, 218–223.
Ma, J. Y. and Narahashi, T. (1993) Differential modulation of GABA-α receptor-channel complex by polyvalent cations in rat dorsal root ganglion neurons. Brain Res., 607, 222–232.
Velez-Pardo, C., Jimenez del Rio, M., Ebinger, G., and Vauquelin, G. (1995) Manganese and Cu promote the binding of dopamine to “serotonin binding proteins” in bovine frontal cortex. Neurochem. Int. 26, 615–622.
Farrar, J. R. and Hoss, W. (1984) Effects of Cu on the binding of agonists and antagonists to muscarinic receptors in rat brain. Biochem. Pharmacol. 33, 2849–2856.
Farrar, J. R., Hoss, W., Herndon, R. M., and Kuzmiak, M. (1985) Characterization of muscarinic cholinergic receptors in the brains of Cu-deficient rats. J. Neurosci. 5, 1083–1089.
Geiger, J. D., Seth, P. K., Klevay, L. M., and Parmar, S. S. (1984) Receptor-binding changes in Cu-deficient rats. Pharmacology 28, 196–202.
Vlachova, V., Zemkova, H., and Vyklicky, L., Jr. (1996) Cu modulation of NMDA responses in mouse and rat cultured hippocampal neurons. Eur. J. Neurosci. 8, 2257–2264.
Fraústo de Silva, J. J. R. and Williams, R. J. P. (1991) In The Biological Chemistry of Elements, Oxford, Clarendon Press, UK.
Linder, M. C. (1991) Biochemistry of Cu, Plenum Press, New York.
Hartter, D. E. and Barnea, A. (1988) Brain tissue accumulates 67Cu by two ligand-dependent saturable processes. A high affinity, low capacity and a low affinity, high capacity process. J. Biol. Chem. 263, 799–805.
Andrews, N. C. (2001) Mining Cu transport genes. Proc. Natl. Acad. Sci. USA 98, 6543–6545.
Hornemann, S., Korth, C., Oesch, B., Riek, R., Wider, G., Wuthrich, K., and Glockshuber, R. (1997) Recombinant full-length murine prion protein, mPrP(23–231): purification and spectroscopic characterization. FEBS Lett. 413, 277–281.
Fridovich, I. (1974) Superoxide dismutases. Ann. Rev. Biochem. 44, 147–159.
Chowdhury, S. K., Eshraghi, J., Wolfe, H., Forde, D., Hlavac, A. G., and Johnston, D. (1995) Mass spectrometric identification of amino acid transformations during oxidation of peptides and proteins: modifications of methionine and tyrosine. Anal. Chem. 67, 390–398.
Fridovich, I. (1997) Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J. Biol. Chem. 272, 18,515–18,517.
Marklund, S. L. (1982) Human Cu-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. USA 79, 7634–7638.
Ookawara, T., Imazeki, N., Matsubara, O., et al. (1998) Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am. J. Physiol. 275, C840–847.
Gohel, C., Grigoriev, V., Escaig-Haye, F., et al. (1999) Ultrastructural localization of cellular prion protein (PrPc) at the neuromuscular junction. J. Neurosci. Res. 55, 261–267
Rodolfo, K., Hassig, R., Moya, K. L., Frobert, Y., Grassi, J., and Di Giamberardino, L. (1999) A novel cellular prion protein isoform present in rapid anterograde axonal transport. Neuroreport 10, 3639–3644.
Brown, D. R. (1999) Prion protein peptide neurotoxicity can be mediated by astrocytes. J. Neurochem. 73, 1105–1113.
Moser, M., Colello, R. J., Pott, U., and Oesch, B. (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14, 509–17.
Brown, D. R., Besinger, A., Herms, J. W., and Kretzschmar, H. A. (1998a) Microglial expression of the prion protein. Neuroreport 9, 1425–1429.
Diomede, L., Sozzani, S., Luini, W., et al. (1996) Activation effects of a prion protein fragment [PrP-(106–126)] on human leucocytes. Biochem. J. 320, 563–570.
Bendheim, P. E., Brown, H. R., Rudelli, R. D., Scala, L. J., et al. (1992) Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42, 149–156.
Brown, H. R., Goller, N. L., Rudelli, R. D., et al. (1990) The mRNA encoding the scrapie agent protein is present in a variety of nonneuronal cells. Acta Neuropathol. 80, 1–6.
Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1998) A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia. Neurobiol. Dis. 4, 410–422.
Thackray, A. M., Knight, R., Haswell, S. J., Bujdoso, R., and Brown, D. R. (2002) Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem. J. 362, 253–258.
Wong, B.-S., Chen, S. G., Colucci, M., et al. (2001) Aberrant metal binding by prion protein in human prion disease. J. Neurochem. 78, 1400–1408.
Raeber, A., Race, R. E., Brandner, S., et al. (1997) Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16, 6057–6065.
Dupuis, L., Mbebi, C., Gonzalez de Aguilar, J. L., et al. (2002) Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis. Mol. Cell Neurosci. 19, 216–224.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Brown, D.R., Sassoon, J. Copper-dependent functions for the prion protein. Mol Biotechnol 22, 165–178 (2002). https://doi.org/10.1385/MB:22:2:165
Issue Date:
DOI: https://doi.org/10.1385/MB:22:2:165